Mei Huang Selected Research

gua lou gui zhi

2/2020	Involvement of PARP-1/AIF Signaling Pathway in Protective Effects of Gualou Guizhi Decoction Against Ischemia-Reperfusion Injury-Induced Apoptosis.
1/2017	Effects of Gualou Guizhi Decoction Aqueous Extract on Axonal Regeneration in Organotypic Cortical Slice Culture after Oxygen-Glucose Deprivation.
7/2015	Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury.
12/2014	Neuroprotective effects of Gualou Guizhi decoction in vivo and in vitro.
7/2014	Effect of Gua Lou Gui Zhi decoction on focal cerebral ischemia-reperfusion injury through regulating the expression of excitatory amino acids and their receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei Huang Research Topics

Disease

52	Neoplasms (Cancer) 07/2022 - 03/2002
21	Infections 01/2022 - 11/2011
21	Schizophrenia (Dementia Praecox) 11/2019 - 11/2005
13	Cognitive Dysfunction 01/2019 - 11/2005
12	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2007
10	Hypoxia (Hypoxemia) 03/2016 - 09/2008
9	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2014
8	Multiple Myeloma 01/2020 - 02/2009
7	Stroke (Strokes) 05/2021 - 12/2014
7	Myocardial Ischemia (Ischemic Heart Diseases) 03/2015 - 09/2008
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2003
6	Leukemia 01/2018 - 10/2002
6	Myocardial Infarction 09/2014 - 01/2010
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 02/2010
5	Hypertension (High Blood Pressure) 01/2020 - 02/2015
4	Hemorrhage 01/2022 - 01/2015
4	Ischemia 12/2021 - 01/2014
4	Inflammation (Inflammations) 07/2021 - 07/2015
4	Syphilis 10/2013 - 03/2012
4	Aspergillosis 05/2013 - 06/2006
3	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022 - 01/2009
3	Coronavirus Infections 01/2022 - 11/2011
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2018
3	Hemophilia A (Haemophilia) 01/2022 - 11/2020
3	Melanoma (Melanoma, Malignant) 12/2021 - 10/2002
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 03/2007
3	Carcinogenesis 01/2021 - 10/2002
3	Reperfusion Injury 02/2020 - 07/2014
3	Bipolar Disorder (Manic Depressive Psychosis) 11/2019 - 07/2006
3	Psychotic Disorders (Schizoaffective Disorder) 11/2018 - 01/2008
3	Adenocarcinoma 01/2018 - 01/2017
3	Pneumonia (Pneumonitis) 01/2018 - 01/2014
3	Weight Loss (Weight Reduction) 10/2017 - 01/2014
3	Carcinoma (Carcinomatosis) 01/2017 - 03/2004
3	Prostatic Neoplasms (Prostate Cancer) 04/2012 - 12/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2005 - 10/2002
2	Thrombosis (Thrombus) 01/2022 - 12/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2015
2	Memory Disorders (Memory Loss) 01/2022 - 01/2019
2	COVID-19 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 04/2017
2	Stomach Neoplasms (Stomach Cancer) 09/2021 - 09/2017
2	Wounds and Injuries (Trauma) 02/2021 - 01/2018
2	Varicose Veins (Varicose Vein) 02/2021 - 01/2015
2	Insulin Resistance 01/2021 - 03/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 05/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2003
11	Pharmaceutical PreparationsIBA 12/2021 - 03/2004
11	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 07/2006
9	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2012
9	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 07/2006
8	Phencyclidine (Angel Dust)IBA 01/2022 - 01/2008
7	Phosphotransferases (Kinase)IBA 01/2022 - 03/2002
7	LigandsIBA 05/2021 - 01/2013
7	Messenger RNA (mRNA)IBA 01/2021 - 09/2010
7	carfilzomibIBA 01/2020 - 10/2013
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2002
6	MicroRNAs (MicroRNA)IBA 01/2016 - 09/2010
6	Clozapine (Clozaril)FDA LinkGeneric 11/2008 - 11/2005
5	AntibodiesIBA 11/2022 - 02/2010
5	CytokinesIBA 01/2022 - 10/2002
5	AntigensIBA 12/2021 - 03/2010
5	Small Interfering RNA (siRNA)IBA 12/2021 - 09/2008
5	Biological ProductsIBA 01/2021 - 11/2012
5	gua lou gui zhiIBA 02/2020 - 07/2014
4	Gemcitabine FDA Link 01/2022 - 10/2016
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2004
4	Circular RNAIBA 01/2020 - 09/2017
4	Therapeutic UsesIBA 01/2020 - 12/2014
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019 - 07/2006
4	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 04/2009
4	EnzymesIBA 01/2017 - 08/2012
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2007 - 03/2002
3	VaccinesIBA 01/2022 - 01/2020
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 11/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2006
3	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 11/2020
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 03/2014
3	Proteasome InhibitorsIBA 10/2019 - 01/2018
3	ImmunosorbentsIBA 01/2017 - 08/2012
3	Neuroprotective AgentsIBA 07/2015 - 12/2014
3	Bevacizumab (Avastin)FDA Link 02/2015 - 11/2014
3	Imatinib Mesylate (Gleevec)FDA Link 06/2006 - 10/2002
2	AutoantibodiesIBA 11/2022 - 01/2009
2	ThioredoxinsIBA 07/2022 - 01/2015
2	triptolideIBA 06/2022 - 02/2013
2	Long Noncoding RNAIBA 06/2022 - 01/2015
2	Rituximab (Mabthera)FDA Link 05/2022 - 01/2017
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 11/2011
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 11/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2021 - 01/2021

Therapy/Procedure

25	Therapeutics 01/2022 - 10/2002
9	Drug Therapy (Chemotherapy) 05/2022 - 01/2006
5	Transplantation 01/2021 - 09/2003
4	Moxibustion 05/2021 - 11/2019
3	Immunotherapy 11/2019 - 09/2003
2	Sclerotherapy 02/2021 - 01/2015
2	Renal Dialysis (Hemodialysis) 05/2020 - 01/2019